YA

Yashsvi Aggarwal

Active Director Director DIN 01984024
DIN 01984024 First appointment May 2000 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since May 2000
Shareholding value •••• Premium profile

About Yashsvi Aggarwal

Data last updated:

Yashsvi Aggarwal is a Director at Organi Botanika India Private Limited (since 2019), Director at Brisc Healthcare Private Limited (since 2020) and Director at Csa Pharma Tech (Pvt) Ltd (since 2000). The companies operate in Pharma, Infrastructure and Utilities and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹11.14 Cr; the largest is Organi Botanika India Private Limited at ₹5.36 Cr (FY 2025). Earlier, Yashsvi Aggarwal was a Director at Walsons Corporation Private Limited (2006–2010) and Director at Frolic Pharmaceuticals Private Limited (from 2000).

DIN 01984024
Primary Designation Director
Industry Pharma
First Appointment 10 May 2000
Oldest Company Age 33 yrs
Largest company Organi Botanika India Private Limited · ₹5.36 Cr (FY 2025)
Combined revenue ₹11.14 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director30 Oct 20192019₹5.36 Cr (FY 2025)Active
Brisc Healthcare Private Limited U24230DL2020PTC373826
Director27 Nov 20202020₹4.02 Cr (FY 2025)Active
Csa Pharma Tech (Pvt) Ltd U51397DL1999PTC100586
Director10 May 20001999₹1.76 Cr (FY 2024)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Walsons Corporation Private Limited U85191DL2006PTC151345
Director27 Jul 20062006Strike Off
Director30 Jun 20001993₹82,055 (FY 2025)Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Brisc Healthcare Private Limited
Organi Botanika India Private Limited
Csa Pharma Tech (Pvt) Ltd
Frolic Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Yashsvi Aggarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yashsvi Aggarwal

Yashsvi Aggarwal currently holds 3 directorships: Organi Botanika India Private Limited (Director, since 30 Oct 2019, revenue ₹5.36 Cr (FY 2025)); Brisc Healthcare Private Limited (Director, since 27 Nov 2020, revenue ₹4.02 Cr (FY 2025)); Csa Pharma Tech (Pvt) Ltd (Director, since 10 May 2000, revenue ₹1.76 Cr (FY 2024)).

Yashsvi Aggarwal was first appointed on 10 May 2000 as Director at Csa Pharma Tech (Pvt) Ltd. The most recent appointment on record is 27 Nov 2020 at Brisc Healthcare Private Limited.

The 3 current companies of Yashsvi Aggarwal that report revenue have a combined latest revenue of ₹11.14 Cr: Organi Botanika India Private Limited ₹5.36 Cr (FY 2025); Brisc Healthcare Private Limited ₹4.02 Cr (FY 2025); Csa Pharma Tech (Pvt) Ltd ₹1.76 Cr (FY 2024).

Yashsvi Aggarwal held 2 earlier board appointments: Walsons Corporation Private Limited (Director, 27 Jul 2006 to 31 Mar 2010); Frolic Pharmaceuticals Private Limited (Director, from 30 Jun 2000).

The current boards of Yashsvi Aggarwal's companies include Anu Aggarwal (Organi Botanika India Private Limited), Gautam Bhalla (Organi Botanika India Private Limited), Sunalini Bhalla (Organi Botanika India Private Limited), Anil Goel (Brisc Healthcare Private Limited), Jitender Goel (Brisc Healthcare Private Limited), Kapil Babu Jain (Brisc Healthcare Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available